ENDRA Life Sciences (NDRA) Assets Average (2017 - 2026)

ENDRA Life Sciences has disclosed Assets Average across 10 years of filings, most recently posting $3.6 million for Q1 2026.

• In Q1 2026, Assets Average fell 4.34% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $3.6 million (down 4.34% YoY), while the FY2025 annual figure was $4.2 million, down 25.88% from the prior year.
• Assets Average climbed to $3.6 million in Q1 2026, from $2.9 million in the prior quarter.
• Over the last five years, Assets Average for NDRA reached as high as $13.8 million in Q3 2022 and fell as low as $2.4 million in Q3 2025.
• The 5-year median for Assets Average is $7.8 million (2024), against an average of $7.4 million.
• Annual changes were most pronounced in 2024 — Assets Average advanced 11.72% — and 2025, when it slumped 74.65%.
• A 5-year view of Assets Average shows it stood at $10.8 million in 2022, then tumbled by 33.58% to $7.2 million in 2023, then fell by 10.63% to $6.4 million in 2024, then tumbled by 54.66% to $2.9 million in 2025, then climbed by 25.34% to $3.6 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $3.6 million, $2.9 million, and $2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.